abstract |
The present invention provides compounds of formula (A) as described herein, and pharmaceutically acceptable salts, enantiomers, rotamers, tautomers or racemates thereof. Also provided are methods of treating diseases or conditions mediated by PIM kinase using the compounds of formula I, and pharmaceutical compositions comprising such compounds. ≪ Formula (A) |